scorecardresearchSolara Active Pharma Sciences Share Price Live NSE, BSE, Today - Solara
Mintgenie
Asian Paints2,870.20-4.15 (-0.14%)
Axis Bank1,064.057.60 (0.72%)
Bajaj Finance7,327.7068.45 (0.94%)
Bajaj Finserv1,630.4510.00 (0.62%)
Bharti Airtel1,336.25-6.05 (-0.45%)
HCL Technologies1,479.65-6.95 (-0.47%)
HDFC Bank1,510.953.75 (0.25%)
Hindustan Unilever2,259.15-3.60 (-0.16%)
ICICI Bank1,094.654.40 (0.40%)
ITC428.85-0.35 (-0.08%)
Indusind Bank1,475.001.30 (0.09%)
Infosys1,431.85-9.85 (-0.68%)
Kotak Mahindra Bank1,843.0529.80 (1.64%)
Larsen & Toubro3,634.9525.00 (0.69%)
Mahindra & Mahindra2,055.00-7.30 (-0.35%)
Maruti Suzuki India12,900.00-93.70 (-0.72%)
NTPC351.254.35 (1.25%)
Nestle India2,502.903.35 (0.13%)
Power Grid Corporation Of India290.005.00 (1.75%)
Reliance Industries2,900.60-17.90 (-0.61%)
State Bank Of India773.000.15 (0.02%)
Sun Pharmaceutical Industries1,486.352.60 (0.18%)
Tata Consultancy Services3,831.25-42.95 (-1.11%)
Tata Motors991.605.00 (0.51%)
Tata Steel165.504.40 (2.73%)
Tech Mahindra1,186.10-14.00 (-1.17%)
Titan Company3,610.00-19.65 (-0.54%)
Ultratech Cement9,672.00140.90 (1.48%)
Wipro460.20-1.80 (-0.39%)

Solara Active Pharma Sciences

BSE: 541540 | NSE: SOLARA | ISIN: INE624Z01016 | SECTOR: Biotechnology & Drugs

₹551.65 4.45 (0.81%)

24 Apr 2024, 10:17 (IST)

  • Open

    550.50

  • High

    567.00

  • Low

    526.60

  • Prev Close

    547.20

  • P/E

    -

  • Median P/E

    -

  • P/B

    -

  • Median P/B

    -

  • Market Cap

    19.86B

  • Volume

    42.43K

  • Vol. (20 day Avg.)

    0

  • PEG

    -

  • Div.Yield

    -

  • Bid

    -

  • Ask

    551.65
View all metrics

Promoter Pledge Holding - 14.63%

Promoter NameNo of SharesPercentage
ARUNKUMAR PILLAI16,68,4634.64%
PRONOMZ VENTURES LLP14,39,2983.99%
CHAYADEEP VENTURES LLP10,12,4002.81%
AGNUS CAPITAL LLP6,14,6351.70%
CHAYADEEP PROPERTIES PVT LTD5,25,7301.46%
KARUNA BUSINESS SOLUTIONS LLP5,7790.01%

Company Description

  • Biotechnology & Drugs

  • BSE

    541540

  • NSE

    SOLARA

  • ISIN

    INE624Z01016

Solara Active Pharma Sciences Limited is an India-based company offering diversified, commercial active pharmaceutical ingredients (APIs) and contract manufacturing services in over 70 countries. The Company operates through the API segment. Its commercial and research and development products include Albendazole, Aprepitant (Antiemetic), Artesunate, Brivaracetam (Antiepileptic), Bumetanide (Inj) (Loop Diuretic), Buspirone HCL (Anxiolytic), Cetirizine Dihydrochloride, Chlorpromazine Hydrochloride, Cinacalcet Hydrochloride (Calcimimetic Agent), Citicoline Sodium (Anticonvulsant), Colchicine (Antigout Agent), Colesevelam Hydrochloride, Cycloserine (Antitubercular), Ethacrynic Acid (Cardiovascular Agent), Hydralazine Hydrochloride (Anti-Hypertensive), Ibuprofen Sodium Dihydrate (Anti-inflammatory), Mesna (Antineoplastic Detoxifying Agent), Mirabegron (OAB Treatment), Pentoxifylline, and others. The Company works with pharmaceutical companies from North America, Europe, and Japan.

Company Officers

  • Poorvank Purohit

    Chief Executive Officer, Managing Director, Director

  • Arun Baskaran

    Chief Financial Officer

  • M. Mohan

    Chief Operating Officer, Additional Executive Director

  • Rajeev Singh

    Chief Human Resource Officer

  • Sudhir Nambiar

    Chief Scientific Officer (Head R&D)

  • S. Murali Krishna

    Compliance Officer, Company Secretary

  • V. Sundara Moorthy

    Chief Quality Officer